Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change
New York, Dec. 18, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change - https://www.reportlinker.com/p05998718/?utm source=GNW
The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77 billion in 2020 at a compound annual growth rate (CAGR) of -3.45%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1.72 billion in 2023 at a CAGR of 30.48%.
Researchers investigate microbiome-mediated therapies for aging and health span
Texas Biomedical Research Institute Associate Professor Corinna Ross, PhD, is a principal investigator on a $3.38 million National Institutes of Health multi-investigator grant to study microbiome-mediated therapies for aging and healthspan in marmosets, which are small monkeys native to South America and are becoming increasingly more important in aging and infectious disease research.
Dr. Ross is partnering with University of Texas at Austin College of Pharmacy Assistant Professor Kelly Reveles, PharmD, PhD.
The United Nations states in its global issues on aging that according to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%).
E-Mail
San Antonio (December 17, 2020) - Texas Biomedical Research Institute Associate Professor Corinna Ross, PhD, is a principal investigator on a $3.38 million National Institutes of Health multi-investigator grant to study microbiome-mediated therapies for aging and healthspan in marmosets, which are small monkeys native to South America and are becoming increasingly more important in aging and infectious disease research. Dr. Ross is partnering with University of Texas at Austin College of Pharmacy Assistant Professor Kelly Reveles, PharmD, PhD.
The United Nations states in its global issues on aging that according to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). Aging is an underlying risk factor for numerous chronic and infectious diseases, so scientists continue to look for interventions that will allow older people to not simply live longer but lead healthier
Share:
New York, Dec. 15, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Clinical Nutrition Global Market Report 2020-30: COVID-19 Growth and Change - https://www.reportlinker.com/p05996811/?utm source=GNW
The global clinical nutrition market is expected to grow from $38.19 billion in 2019 to $42.86 billion in 2020 at a compound annual growth rate (CAGR) of 12.23%. The growth is mainly due to the COVID-19 outbreak. Nutritional care is believed to influence recovery time and the patient s ability to return to normal. Nutrition is vital in maintaining avoiding metabolic disturbances during the patient s stay (around two weeks) in the intensive care. Also, as respiratory difficulties prevent patients from eating effectively, nutritional intake is important. The market is then expected to stabilize and reach $52.76 billion in 2023 at a CAGR of 7.18%.
Advocating for senior citizens in an aging world
More than 500 million people aged 65 and above over half the age group currently live in cities, with the majority living in low- and middle-income countries.
[2] This rapidly aging urban population requires an understanding of the factors that affect older people in the cities where they live. Also, as cities may further marginalize those already excluded from spaces, services, and society in older age, the demand for relevant data and evidence that would hold stakeholders accountable in delivering improvements that benefit older people and the broader communities is increasing.
Image from HelpAge International